A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.